PMDA drug package insert
バテ９
PMDA OTC drug · 株式会社奈良大和生薬 · package insert May 27, 2024
Key facts
| Brand names | バテ９ |
|---|---|
| Companies | 製造販売元／剤盛堂薬品（株）,販売会社／株式会社奈良大和生薬 |
| Product type | OTC drug |
| OTC risk class | なし |
| OTC dosage form | カプセル |
| OTC effect category | ビタミン含有保健薬（ビタミン剤等） |
| Package insert date | May 27, 2024 |
| PMDA document key | 300009_K2405000020 |
| PMDA company code | 300009 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: